Sanjaya Gupta, MD
Clinical Cardiac Electrophysiology · Kansas City, MONPI 1700904182
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $237,311 of the $316,372 with a category attached, or 75.0%. 16 manufacturers reported payments, led by Boston Scientific at 38.8% of the total. Among clinical cardiac electrophysiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 397 payments — averaging $796.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$123K
- ZOLL Respicardia, Inc.$79K
- Medtronic$74K
- Cordis US CORP.$18K
- Abbott$15K
- Sanofi-aventis U.S. LLC$3K
- plus $5K from 10 others
Across 156 payments — averaging $6430.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$370K
- Boston Scientific$285K
- Abbott$245K
- Cordis US CORP.$85K
- E.r. Squibb & Sons, L.L.C.$18K
What the payments were for
- Consulting fees$29,9259%
- Speaking & faculty fees$237,31175%
- Travel & lodging$32,29610%
- Food & beverage$16,8265%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 151 | $122,705 |
| ZOLL Respicardia, Inc. | 33 | $78,568 |
| Medtronic(2 entities) | 136 | $73,502 |
| Cordis US CORP. | 16 | $18,202 |
| Abbott | 42 | $15,340 |
| Sanofi-aventis U.S. LLC | 1 | $2,967 |
| Altathera Pharmaceuticals LLC | 3 | $2,233 |
| Cardiva Medical, Inc. | 2 | $1,520 |
| Biosense Webster, Inc. | 4 | $516 |
| Impulse Dynamics (USA) Inc. | 2 | $345 |
| Siemens Medical Solutions USA, Inc. | 1 | $144 |
| Synaptic Medical Corporation | 1 | $120 |
| Biotronik Inc. | 1 | $92 |
| Irhythm Technologies, Inc. | 2 | $85 |
| Penumbra, Inc. | 1 | $19 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$78,310
- WATCHMAN Access System$40,056
- GENERAL - THERAPIES$25,763
- WATCHMAN FLX$13,517
- Arctic Front$9,418
- ARCTIC FRONT ADVANCE$8,065
- MYNX CONTROL$6,869
- MYNX CONTROL VENOUS$5,770
- PERCLOSE PROGLIDE$4,650
- ENSITE$4,025
- Farapulse$3,910
- Sotalol Hydrochloride$2,233
- Perclose ProGlide suture mediated closure system$2,125
- S-ICD System Magnet$1,750
- ADVISOR$1,575
- Mynx Venous VCD$1,545
- Cardiva VASCADE MVP VVCS 6-12F$1,500
- EMBLEM$1,400
- AVEIR$1,293
- EMBLEM MRI S-ICD$750
How this compares
$316,372 in reported general payments places this provider in the 95th percentile of 74 clinical cardiac electrophysiology providers in Missouri.
See all clinical cardiac electrophysiology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 509 | $554,978 |
| XareltoRivaroxaban | 108 | $113,706 |
| EntrestoSacubitril/Valsartan | 35 | $45,891 |
| JardianceEmpagliflozin | 33 | $35,514 |
| Dofetilide | 127 | $17,149 |
| FarxigaDapagliflozin Propanediol | 18 | $15,802 |
| Flecainide Acetate | 159 | $9,560 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 154 | $3,790 |
| Metoprolol Succinate | 251 | $2,717 |
| Prasugrel Hcl | 11 | $2,609 |
| Atorvastatin Calcium | 191 | $2,111 |
| Carvedilol | 170 | $1,908 |
| Potassium Chloride | 62 | $1,320 |
| Propafenone Hcl | 13 | $1,302 |
| SotalolSotalol Hcl | 58 | $1,153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $14 | $15,80218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 74 clinical cardiac electrophysiology providers in Missouri.
Other clinical cardiac electrophysiology in Kansas City
- Jessica KlineKansas City$75K
- Daniel SteinhausKansas City$28K
- Alan WimmerKansas City$18K
- Luis CouchonnalKansas City$15K
- Alejandro Perez-VerdiaKansas City$7K
- Brian RamzaKansas City$4K
- Phillip CuculichSaint Louis$473K
- Daniel CooperSaint Louis$168K
- Mahmoud ElsayedNorth Kansas City$67K
- Scott KoerberIndependence$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.